Related references
Note: Only part of the references are listed.Guanidinylations of albumin decreased binding capacity of hydrophobic metabolites
M. Rueth et al.
ACTA PHYSIOLOGICA (2015)
Release of Uremic Retention Solutes from Protein Binding by Hypertonic Predilution Hemodiafiltration
Falko Boehringer et al.
ASAIO JOURNAL (2015)
Emerging role of post-translational modifications in chronic kidney disease and cardiovascular disease
Prathibha R. Gajjala et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2015)
Measuring Unbound Versus Total Vancomycin Concentrations in Serum and Plasma: Methodological Issues and Relevance
Veronique Stove et al.
THERAPEUTIC DRUG MONITORING (2015)
Protein-bound solute removal during extended multipass versus standard hemodialysis
Sunny Eloot et al.
BMC NEPHROLOGY (2015)
Unbound Fraction of Vancomycin in Intensive Care Unit Patients
Martin G. Kees et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2014)
The Uremic Toxicity of Indoxyl Sulfate and p-Cresyl Sulfate: A Systematic Review
Raymond Vanholder et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2014)
Protein-Bound Molecules: A Large Family With a Bad Character
Tammy L. Sirich et al.
SEMINARS IN NEPHROLOGY (2014)
Binding Affinity and Capacity for the Uremic Toxin Indoxyl Sulfate
Eric Devine et al.
TOXINS (2014)
Albumin is the main plasma binding protein for indoxyl sulfate and p-cresyl sulfate
Liesbeth Viaene et al.
BIOPHARMACEUTICS & DRUG DISPOSITION (2013)
Does P-Cresylglucuronide Have the Same Impact on Mortality as Other Protein-Bound Uremic Toxins?
Sophie Liabeuf et al.
PLOS ONE (2013)
Does the Adequacy Parameter Kt/Vurea Reflect Uremic Toxin Concentrations in Hemodialysis Patients?
Sunny Eloot et al.
PLOS ONE (2013)
Host factors affecting antiepileptic drug delivery-Pharmacokinetic variability
Cecilie Johannessen Landmark et al.
ADVANCED DRUG DELIVERY REVIEWS (2012)
Normal and Pathologic Concentrations of Uremic Toxins
Flore Duranton et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2012)
Novel method for simultaneous determination of p-cresylsulphate and p-cresylglucuronide: clinical data and pathophysiological implications
Natalie Meert et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2012)
Vascular Incompetence in Dialysis Patients-Protein-Bound Uremic Toxins and Endothelial Dysfunction
Noemie Jourde-Chiche et al.
SEMINARS IN DIALYSIS (2011)
Free p-cresylsulphate is a predictor of mortality in patients at different stages of chronic kidney disease
Sophie Liabeuf et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2010)
Serum Indoxyl Sulfate Is Associated with Vascular Disease and Mortality in Chronic Kidney Disease Patients
Fellype C. Barreto et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
Sodium octanoate to reverse indoxyl sulfate and p-cresyl sulfate albumin binding in uremic and normal serum during sample preparation followed by fluorescence liquid chromatography
Henriette de Loor et al.
JOURNAL OF CHROMATOGRAPHY A (2009)
A review of albumin binding in CKD
Bjoern K. I. Meijers et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2008)
Review on uremic toxins:: Classification, concentration, and interindividual variability
R Vanholder et al.
KIDNEY INTERNATIONAL (2003)
Behavior of non-protein-bound and protein-bound uremic solutes during daily hemodialysis
RM Fagugli et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2002)
Share Paper
